Date Time
UC Davis MIND Institute to host inaugural stem cell, gene therapy conference
This fall, the UC Davis MIND Institute will host a brand-new conference focused on the development of effective genetic and stem cell treatments for children with neurodevelopmental conditions such as autism, fragile X syndrome, Rett syndrome, Dravet syndrome, Angelman syndrome and others. The inaugural Stem Cell and Gene Therapy for Neurodevelopmental Disorders Conference will be Sept. 24-25.
Abstracts are currently being accepted for the inaugural Stem Cell and Gene Therapy for Neurodevelopmental Disorders Conference and are due May 17. The event will take place Sept. 24-25, and current plans include options for either in-person or virtual attendance. Limited abstract awards will be offered to graduate students and postdoctoral fellows.